InvestSMART

Reva Medical Inc (ASX: RVA) - Announcements

DELISTED - Current share price for RVA : $0.170

ASX company news and announcements for Reva Medical Inc (RVA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Reva Medical Inc (RVA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Reva Medical Inc (RVA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Reva Medical Inc (RVA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 4C - quarterly 29 Apr 2016 8:40AM $1.050 $0.170 fallen by 83.81%
- Change of Director's Interest Notice 6 Apr 2016 12:23PM $1.100 $0.170 fallen by 84.55%
- Change of Director's Interest Notice 31 Mar 2016 12:23PM $1.110 $0.170 fallen by 84.68%
- Brian Dovey Elected Chairman 30 Mar 2016 10:06AM $1.120 $0.170 fallen by 84.82%
- Results of Special Meeting 23 Mar 2016 1:03PM $1.100 $0.170 fallen by 84.55%
- Details for Special Meeting of Stockholders 16 Mar 2016 9:28AM $1.110 $0.170 fallen by 84.68%
- Annual Report on Form 10-K 11 Mar 2016 9:35AM $1.110 $0.170 fallen by 84.68%
- Form S-8 Filed with SEC 11 Mar 2016 9:29AM $1.110 $0.170 fallen by 84.68%
- S&P DJ Indices Announces March Quarterly Review 11 Mar 2016 8:25AM $1.110 $0.170 fallen by 84.68%
- Proxy Statement for Special Meeting of Stockholders 9 Mar 2016 4:52PM $1.130 $0.170 fallen by 84.96%
- Notice of Briefing Call 8 Mar 2016 12:44PM $1.120 $0.170 fallen by 84.82%
- Preliminary Final Report 26 Feb 2016 4:15PM $1.130 $0.170 fallen by 84.96%
- FANTOM II Target Patient Enrollment Achieved 24 Feb 2016 9:11AM $1.130 $0.170 fallen by 84.96%
- Appendix 3B 22 Feb 2016 4:10PM $1.150 $0.170 fallen by 85.22%
- Notice of Change of Substantial Holders 16 Feb 2016 11:05AM $1.190 $0.170 fallen by 85.71%
- Becoming a substantial holder 16 Feb 2016 10:25AM $1.190 $0.170 fallen by 85.71%
- Appendix 3B 16 Feb 2016 9:51AM $1.190 $0.170 fallen by 85.71%
- Clinical Progress & Anticipated $11.4 Million Cash Receipt 11 Feb 2016 9:37AM $1.140 $0.170 fallen by 85.09%
- Appendix 4C - quarterly 29 Jan 2016 8:58AM $1.120 $0.170 fallen by 84.82%
- Richard Kimes Hired as SVP of Operations 20 Jan 2016 9:16AM $0.935 $0.170 fallen by 81.82%
- Presentation at J.P. Morgan Healthcare Conference 15 Jan 2016 8:26AM $0.940 $0.170 fallen by 81.91%
- REVA to Present at J.P. Morgan Healthcare Conference 8 Jan 2016 8:49AM $0.870 $0.170 fallen by 80.46%
- Appendix 3B 17 Dec 2015 2:26PM $0.880 $0.170 fallen by 80.68%
- Notice of Change of Substantial Holders 23 Nov 2015 9:48AM $0.840 $0.170 fallen by 79.76%
- Quarterly Report on Form 10-Q 10 Nov 2015 9:30AM $0.840 $0.170 fallen by 79.76%

201 - 225 of 302 results

Page 9 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.